Vnitr Lek 2007, 53(10):1123-1126

Výsledky studie ADVANCE

P. Havránek
Interní oddělení nemocnice České Budějovice

Received: October 15, 2007; Published: October 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Havránek P. Výsledky studie ADVANCE. Vnitr Lek. 2007;53(10):1123-1126.
Download citation

References

  1. Patel A and ADVANCE Collaborating Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370: 829-870. Go to original source... Go to PubMed...
  2. Amos AF et al. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 2006; 14 (Suppl. 5): S1-S15. Go to original source...
  3. Estacio RO, Jeffers BW, Gifford N et al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000; 23 (Suppl. 2): B54-B64. Go to PubMed...
  4. Schrier RW, Estacio RO, Jeffers B Appropriate Blood Pressure Control in NIDDM (ABCD) trial. Diabetologia 1996; 39: 1646-1654. Go to original source... Go to PubMed...
  5. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145-153. Go to original source... Go to PubMed...
  6. Schrier RW, Estacio RO Additional follow-up from the ABCD trial in patients with type 2 diabetes and hypertension. N Engl J Med 2000; 343: 1969. Go to original source... Go to PubMed...
  7. McInnes GT The Differences Between ACE Inhibitor-Treated and Calcium Channel Blocker-Treated Hypertensive Patients. J Clin Hypertens (Greenwich) 2003; 5: 337-344. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.